This is the authors' abstract. We don't add key points for this paper.
New technologies for mutation detection in the human genome have greatly increased our understanding of epilepsy genetics. Application of genomic technologies in the clinical setting allows for more efficient genetic diagnosis in some patients; therefore, it is important to understand the types of tests available and the types of mutations that can be detected. Making a genetic diagnosis improves overall patient care by enhancing prognosis and recurrence risk counseling and informing treatment decisions.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Heather C. Mefford (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: